Proteomic Analysis of Human Plasma during Intermittent Fasting
Harney DJ, Hutchison AT, Hatchwell L, Humphrey SJ, James DE, Hocking S, Heilbronn LK, Larance M
Journal of proteome research · 99 citas
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
- Universidad u hospital
- Cancer Institute NSW
- Gobierno
- Australian Research Council
- Gobierno
- National Health and Medical Research Council
- Subvenciones
- Australian Research Council (FT120100027); Cancer Institute NSW (15/FRL/1-06A); National Health and Medical Research Council (1023401); National Health and Medical Research Council (1120475)
Según 3 financiadores declarados y la declaración de financiación del texto completo.
Publicación
- Publicado
- 2019-03-20 · J Proteome Res · vol. 18 · número 5 · págs. 2228–2240
- Editorial
- American Chemical Society
- Citado
- 116 citas · más que el 96% de estudios similares · 5.1× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 72 trabajos
- Acceso
- Acceso abierto (revista híbrida) · OTHER-OA
- Áreas de investigación
- Dietary Effects on Health · Adipose Tissue and Metabolism · Adipokines, Inflammation, and Metabolic Diseases
- Palabras clave
- Human plasma, Chemistry, Computational biology, Biology, Chromatography
- MeSH
- humans, triglycerides, lipoproteins, hdl, apolipoproteins a, specimen handling, chromatography, liquid, fasting, longitudinal studies, proteomics, gene expression, particle size, databases, protein, adult, aged, middle aged, female, lipid metabolism, apolipoprotein c-ii, apolipoprotein c-iii, tandem mass spectrometry, solid phase extraction, printing, three-dimensional
8 autores
- Dylan Harney🇦🇺The University of Sydney
- Amy T. Hutchison🇦🇺The University of Adelaide
- Luke Hatchwell🇦🇺The University of Sydney
- Sean J. Humphrey🇦🇺The University of Sydney
- David Ernest James🇦🇺The University of Sydney
- SAMANTHA L. HOCKING🇦🇺The University of Sydney
- Leonie Kaye Heilbronn🇦🇺 · autor de correspondenciaThe University of Adelaide
- Mark Larance🇦🇺 · autor de correspondenciaThe University of Sydney
Resumen
El texto original del estudio, en el idioma en que se publicó.
Intermittent fasting (IF) increases lifespan and decreases metabolic disease phenotypes and cancer risk in model organisms, but the health benefits of IF in humans are less clear. Human plasma derived from clinical trials is one of the most difficult sample sets to analyze using mass spectrometry-based proteomics due to the extensive sample preparation required and the need to process many samples to achieve statistical significance. Here, we describe an optimized and accessible device (Spin96) to accommodate up to 96 StageTips, a widely used sample preparation medium enabling efficient and consistent processing of samples prior to LC-MS/MS. We have applied this device to the analysis of human plasma from a clinical trial of IF. In this longitudinal study employing 8-weeks IF, we identified significant abundance differences induced by the IF intervention, including increased apolipoprotein A4 (APOA4) and decreased apolipoprotein C2 (APOC2) and C3 (APOC3). These changes correlated with a significant decrease in plasma triglycerides after the IF intervention. Given that these proteins have a role in regulating apolipoprotein particle metabolism, we propose that IF had a positive effect on lipid metabolism through modulation of HDL particle size and function. In addition, we applied a novel human protein variant database to detect common protein variants across the participants. We show that consistent detection of clinically relevant peptides derived from both alleles of many proteins is possible, including some that are associated with human metabolic phenotypes. Together, these findings illustrate the power of accessible workflows for proteomics analysis of clinical samples to yield significant biological insight.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.